1-Isopropyl-1H-pyrazole-4-carbaldehyde

Catalog No. :
ACTIPJ022
CAS No. :
313735-67-0
Molecular Formula :
C7H10N2O
Molecular Weight :
138.17

IUPAC Name:1-Isopropyl-1H-pyrazole-4-carbaldehyde

1-Isopropyl-1H-pyrazole-4-carbaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$92.00Login to see priceIn stockInquiry
25g97%$400.00Login to see priceIn stockInquiry
100g97%$1251.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Isopropyl-1H-pyrazole-4-carbaldehyde
IUPAC Name1-Isopropyl-1H-pyrazole-4-carbaldehyde
MDL No.MFCD06260724
Molecular FormulaC7H10N2O
Molecular Weight138.17
SMILESO=CC1=CN(C(C)C)N=C1
InChI KeyJTOWCZGTZBCRNY-UHFFFAOYSA-N
SynonymAKOS PAO-0278;1H-Pyrazole-4-carboxaldehyde, 1-(1-methylethyl)- (9CI);1-Isopropyl-1H-pyrazole-4-carboxaldehyde;CHEMBRDG-BB 4003133;1-ISOPROPYL-1H-PYRAZOLE-4-CARBALDEHYDE;1-isopropyl-1H-pyrazole-4-carbaldehyde(SALTDATA: FREE);1-isopropyl-4-pyrazolecarboxaldehyde;1-isopropylpyrazole-4-carbaldehyde
CAS No.313735-67-0
PubChem CID5230536

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTIPJ022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQBVY936 route compound structure diagram
    ACQBVY9361197230-88-8 In Stock
  4. Then
  5. ACTIPJ022 route product structure diagram
    ACTIPJ022313735-67-0 In Stock
Inquiry

2. ACTIPJ022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOJX073 route compound structure diagram
    ACTOJX073313735-62-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTIPJ022 route product structure diagram
    ACTIPJ022313735-67-0 In Stock
Inquiry

Comments (0)